期刊文献+

^(99m)Tc-TRODAT-1单光子放射计算机断层显像早期诊断帕金森病的研究 被引量:2

Study on ^(99m)Tc-TRODAT-1 SPECT in diagnosis of early Parkinson's disease
下载PDF
导出
摘要 目的 探讨99mTc TRODAT 1单光子放射计算机断层显像 (SPECT)早期诊断帕金森病 (PD)的价值。方法 分别对PD组和正常对照组进行99mTc TRODAT 1SPECT脑显像 ,使用SiemensECAMSPECT双探头。从横断面上选出基底节最清晰的一层进行相对定量分析 ,应用计算机感兴趣区 (ROI)技术在图像上分别勾划基底节 (BG)和枕叶 (OC)ROI,计算BG/OC放射性比值。结果 PD组 2 2例 ,按改良Hoehn和Yahn评分 :1级组 8例 ,1.5级组 14例 ;对照组 6例。99mTc TRODAT 1SPECT脑显像示 ,PD患者症状对侧BG受损情况明显重于症状同侧BG ,与正常对照组比较有明显的差异。BG/OC比值显示 :1级和 1.5级PD患者的症状对侧BG/OC比值均显著低于症状同侧 (P <0 .0 1) ;1.5级PD患者两侧BG/OC平均值 (1.2 0± 0 .17)与对照组 (1.5 5± 0 .12 )比较 ,差异有显著性 (P <0 .0 0 1) ;1级PD患者症状对侧BG/OC(1.34± 0 .13)与 1.5级 (1.17± 0 .16 )比较 ,差异有显著性 (P <0 .0 5 ) ;1级PD患者两侧BG/OC平均值 (1.4 0± 0 .15 )与对照组 (1.5 5± 0 .12 )比较 ,差异无显著性 (P >0 .0 5 ) ;1级与 1.5级PD患者的BG/OC平均值之间差异有显著性 (P <0 .0 5 )。正常对照组BG/OC比值显著高于PD组 (1级和 1.5级 ) (P <0 .0 0 1)。1级与 1.5级PD患者症状同侧的BG/ Objective To assess the value of 99m Tc TRODAT 1 SPECT in diagnosis of early Parkinson's disease(PD). Methods Twenty two patients of early idiopathic PD were studied with 99m Tc TRODAT 1 SPECT. For all patients, the PD was stage 1.5 or less as assessed by the new Hoehn and Yahr scale. Six age matched healthy volunteers (4 men, 2 women) served as controls. 99m Tc TRODAT 1 was prepared from a lyophilized kit. Brain imaging was performed on a dual head camera between 2 ~ 4 h after injection of 1 110 MBq (30mCi) 99m Tc TRODAT 1. Mean counts per pixel were measured manually in the region below the basal ganglia (BG) and normalized to the mean background counts to give specific uptake values (BG/OC). Logistic discriminant analyses were performed to determine the optimum uptake value for differentiating the patients from the controls. Results Quantitative imaging analysis showed that in the Hoehn and Yahn 1 PD and 1.5 PD groups mean the BG/OC (1.40±0.15, 1.20±0.17 respectively)value were less than those in the controls (1.55±0.12) ( P <0.01, P <0.001 respectively). The mean values of specific BG uptake contralateral to the more affected limbs were significantly decreased compared with the ipsilateral sides in both stage 1 and 1.5 groups (1.34±0.13 vs 1.45±0.18, P <0.01, for stage 1 and 1.17±0.16 vs 1.23±0.18, P <0.01, for stage 1.5). No remarkable adverse reactions were found either in the patients or the controls during or after imaging. Conclusion 99m Tc TRODAT 1 SPECT and basal ganglia uptake may serve as a useful imaging method for early detection of Parkinson's disease.
出处 《上海医学》 CAS CSCD 北大核心 2002年第10期607-609,I002,共4页 Shanghai Medical Journal
关键词 早期诊断 ^99MTC-TRODAT-1 多巴胺转运蛋白 单光子放射计算机断层显像术 帕金森病 m Tc TRODAT 1 Dopamine transporter SPECT Parkinson's disease
  • 相关文献

参考文献8

  • 1Kung HF, Kim HJ, Kung MP,et al. Imaging of dopamine trans porters in humans with technetium-99mTRODAT-1. Eur J Nucl Med, 1996,23: 1527 1530.
  • 2刘兴党,林祥通,方平,周翔,陈正平,王博诚,张满达.中枢多巴胺转运蛋白显像剂^(99)Tc^m-TRODAT-1的实验研究[J].中华核医学杂志,2000,20(6):285-286. 被引量:5
  • 3Huang WS, Lin SZ, Lin JC. et al. Evaluation of early-stage Parkinson' s disease with 99m Tc-TRODAT-1 imaging. J Nucl Med,2001, 42: 1303-1308.
  • 4方平,吴春英,陈正平,周翔,万卫星,纪书仁.多巴胺转运蛋白显像剂^(99)Tc^m-TRODAT-1的制备及动物实验[J].中华核医学杂志,1999,19(3):146-148. 被引量:30
  • 5Bao SY, Wu JC, Luo WF, et al. Imaging of dopamine trans porters with technetium-99m TRODAT-1 and single photon emission computed tomography. J Neuroimaging,2000, 10: 200-203.
  • 6Mozley PD, Schneider JS, Acton PD, et al. Binding of [99mTc]TRODAT 1 to dopamine transporters in patients with Parkinson' s disease and in health volunteers. J Nucl Med,2000, 4: 584-589.
  • 7Frost J J, Rosier AJ, Reich SG, et al. Positron emission tomographic imaging of the dopamine transporter with 1 1C WIN 35,428 reveals marked decline in mild Parkinson's disease. Ann Neu rol,1993, 34: 423-431.
  • 8Kao PF, Tzen KY, Yen TC, et al. The optimal imaging time for [99Tcm] TRODAT 1/SPECT in normal subjects and patients with Parkinson' s disease. Nucl Med Commun, 2001,22: 151 - 154.

二级参考文献7

  • 1Kung M P,Eur J Nucl Med,1997年,24卷,372页
  • 2Kung H F,Eur J Nucl Med,1996年,23卷,1527页
  • 3Meltzer P C,J Med Chem,1993年,36卷,855页
  • 4Yung B C K,J Nucl Med,1993年,34卷,197页
  • 5Kung M P,Eur J Nucl Med,1997年,24卷,372页
  • 6Kung H F,Eur J Nucl Med,1996年,23卷,1527页
  • 7方平,吴春英,陈正平,周翔,万卫星,纪书仁.多巴胺转运蛋白显像剂^(99)Tc^m-TRODAT-1的制备及动物实验[J].中华核医学杂志,1999,19(3):146-148. 被引量:30

共引文献31

同被引文献47

  • 1[1]Kung HF, Kim HJ, Kung MP, et al. Imaging of dopamine transporters in humans with technetium-99m TRODAT-1 [J]. Eur J Nucl Med, 1996, 23(11): 1 527-1 530.
  • 2[2]Meegalla SK, Plossl K, Kung MP, et al. Synthesis and characterization of technetium-99m-labeled tropanes as dopamine transporter-imaging agents[J]. J Med Chem,1997 ,40(1):9-17.
  • 3[3]Kung MP, Stevenson DA,Plossl K,et al.[99mTc]TRODAT-1:a novel technetium-99m complex as a dopamine transporter imaging agent[J].Eur J Nucl Med,1997,24(4):372-380.
  • 4[4]Fang P, Wu CY, Liu ZG, et al. The preclinical pharmacologic study of dopamine transporter imaging agent [99mTc]TRODAT-1[J]. Nucl Med Biol,2000 ,27(1):69-75.
  • 5[5]Scherfler C, Donnemiller E, Schocke M, et al. Evaluation of striatal dopamine transporter function in rats by in vivo beta-123I CIT pinhole SPECT[J]. Neuroimage,2002 ,17(1):128-141.
  • 6[6]Simpkins N, Jankovic J. Neuroprotection in Parkinson disease[J]. Arch Intern Med,2003,28;163(14):1 650-1 654.
  • 7[7]Kaufman MJ, Madras BK. Severe depletion of cocaine recognition sites associated with the dopamine transporter in Parkinson's-diseased striatum[J]. Synapse, 1991,49(9):43-49.
  • 8[8]Becker G. Methods for the early diagnosis of Parkinson's disease[J]. Nervenarzt, 2003 ,74 (Sup):S7-11.
  • 9[9]Booij J, Tissingh G, Boer GJ, et al. 123IFP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease[J]. J Neurol Neurosurg Psychiatry, 1997 ,62(2):133-140.
  • 10[10]Hamano T, Tsuchida T, Hirayama M, et al. Dopamine transporter SPECT in patients with Parkinson's disease[J]. Kaku Igaku,2000 ,37(2):125-129.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部